0001375151-20-000115.txt : 20200630 0001375151-20-000115.hdr.sgml : 20200630 20200629215320 ACCESSION NUMBER: 0001375151-20-000115 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200625 FILED AS OF DATE: 20200629 DATE AS OF CHANGE: 20200629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galer Bradley S. CENTRAL INDEX KEY: 0001594565 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34962 FILM NUMBER: 201000199 MAIL ADDRESS: STREET 1: C/O ZOGENIX, INC. STREET 2: 12400 HIGH BLUFF DR., SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZOGENIX, INC. CENTRAL INDEX KEY: 0001375151 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205300780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 550-8300 MAIL ADDRESS: STREET 1: 5959 HORTON STREET, SUITE 500 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: ZOGENIX INC DATE OF NAME CHANGE: 20060911 4 1 wf-form4_159348195885012.xml FORM 4 X0306 4 2020-06-25 0 0001375151 ZOGENIX, INC. ZGNX 0001594565 Galer Bradley S. C/O ZOGENIX, INC. 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 0 1 0 0 EVP/Chief Medical Officer Common Stock 2020-06-25 4 M 0 10000 0 A 20015 D Common Stock 2020-06-25 4 F 0 2813 28.12 D 17202 D Restricted Stock Units 2020-06-25 4 M 0 10000 0 D Common Stock 10000.0 0 D The Restricted Stock Units (RSUs) were granted on March 14, 2017, with 100% of the RSUs to vest upon approval of the Company's New Drug Application (NDA) by the U.S. Food and Drug Administration for Fintepla. The NDA was approved on June 25, 2020. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of RSUs described in footnote 1. Each RSU represents a contingent right to receive one share of Zogenix common stock. Not applicable. /s/ Thomas Doyle, Attorney-in-fact for Bradley Galer 2020-06-29